IR CPT 37236 Revenue Insights — Boosting Net Worth

Where IR Physicians Stand Financially Right Now

This substantial figure reflects the growing financial strength of IR physicians driven by strategic practice management and investment decisions.

On a regional level, net worth can vary significantly, with physicians in major metropolitan areas often reporting higher figures than those in smaller markets, due in part to factors like procedure volumes, reimbursement rates, and cost of living.

Diversifying income through real estate investments and ownership in ambulatory surgery centers can be a strategy for increasing net worth. These investment strategies are particularly notable in markets like Austin and Denver, where real estate values have shown consistent appreciation.

Moreover, a trend towards incorporating telemedicine services has allowed some IR physicians to expand their practice reach. This additional income stream is becoming a significant factor in financial planning for IRs across different regions.

For those looking to understand the income dynamics in different locations, Repit Housing Data offers valuable insights into real estate trends and their potential impact on physician net worth.

The Numbers — Income Benchmarks, Net Worth Data

Analyzing the income benchmarks for IR physicians, we find a substantial portion of revenue derived from key procedures. Specifically, CPT 37236 and 37221 are significant contributors to the annual income, with Medicare reimbursements showing consistent growth. For instance, CPT 37236 shows an average reimbursement of $1,200 per procedure based on CMS data. This has allowed IRs to structure their practices around high-yield procedures, enhancing overall financial stability.

Assuming an average annual procedural volume of 250 CPT 37236 cases, this translates to a gross revenue of $300,000 solely from this code. When combined with other procedures like 37220 and 75710, the cumulative impact on net worth becomes evident. This data is sourced from the CMS Machine Readable Files and OPPS 2026, providing a reliable foundation for financial planning.

What Drives the Gap — OBL Ownership, ASC Stakes, Practice Structure

The financial gap between Interventional Radiology (IR) physicians and peers in other specialties often narrows through strategic ownership stakes in Office-Based Labs (OBLs) and Ambulatory Surgical Centers (ASCs). Physicians with equity in OBLs may see an increase in annual passive income, depending on location and patient volume. The return on investment in OBLs can vary by market.

These investments are vital for boosting net worth, as they offer not only passive income but also potential tax advantages and asset appreciation over time. In the ASC sector, IRs who participate in ownership may benefit from an increase in annual earnings. This is largely due to higher reimbursement rates associated with procedures performed in ASCs compared to hospital settings, coupled with lower operational costs. ASCs in the Midwest may have lower operating costs compared to coastal regions, which can enhance profitability for physician owners.

Furthermore, optimizing practice structures to include efficient patient flow and innovative technologies, such as telemedicine or AI imaging diagnostics, can contribute significantly to financial growth. Leveraging these technologies is intended to help reduce overhead and increase patient throughput, thereby maximizing revenue potential. These strategic decisions and investments enable IR physicians to bridge the financial gap effectively and ensure long-term fiscal health.

Comparing Specialties — IR vs Other Proceduralists

When comparing IR physicians to other proceduralists, strategic practice management emerges as a pivotal factor. For example, cardiologists and orthopedic surgeons report median annual incomes of approximately $430,000 and $482,000, respectively, according to the Medscape Physician Compensation Report 2023. In contrast, interventional radiologists (IRs) have strategically closed the income gap by emphasizing high-revenue procedures.

IRs have increasingly focused on procedures indexed under CPT 37236, which involves endovascular repair of blood vessels. These procedures not only command significant reimbursement rates but also align with the growing demand for minimally invasive interventions. Demand for IR procedures has grown in recent years.

This strategic focus has allowed IRs to enhance their income potential, with many now reporting median earnings close to $420,000, a substantial increase from previous years. Furthermore, IRs have diversified their services to include embolization and thrombolysis, which are in high demand, particularly in urban markets like New York City and Los Angeles.

In terms of net worth benchmarks, IRs are leveraging these high-revenue procedures to narrow the disparity with traditionally higher-earning specialties. This is contingent on sustained growth in procedural demand and effective practice management.

Strategic Considerations — What Moves the Needle Most

To significantly impact net worth, IR physicians should prioritize high-yield procedural codes, such as transjugular intrahepatic portosystemic shunt (TIPS) and embolization procedures, which can generate upwards of $3,000 per procedure. Additionally, investing in related healthcare facilities like outpatient imaging centers can yield substantial returns.

Ownership stakes in freestanding ambulatory surgery centers can also be lucrative. Diversifying investments to include real estate holdings within healthcare parks can provide stable, long-term income.

Engaging with educational platforms such as the GigHz Academy can provide further guidance on optimizing income strategies, offering courses on maximizing return on investment (ROI) and navigating the complexities of healthcare financial management. Moreover, leveraging group purchasing organizations (GPOs) for interventional radiology supplies can help reduce costs, further enhancing profitability.

Finally, understanding regional market dynamics is crucial; for example, physicians practicing in metropolitan areas like New York or Los Angeles might see higher revenue potential due to larger patient volumes and higher reimbursement rates. Adjusting strategic priorities to align with these market-specific opportunities can significantly enhance an IR physician’s financial trajectory.

Methodology & Data Sources

The data presented in this analysis is derived from the CMS Machine Readable Files and OPPS 2026, which provide comprehensive insights into healthcare billing and reimbursement trends. The calculations assume a procedural mix that maximizes revenue from the CPT codes 37220, 37221, 75710, 75625, and 37236. These codes are associated with interventional radiology procedures known to significantly impact physician revenue streams.

CPT code 37220, for instance, involves revascularization of the iliac artery and is estimated to account for approximately 15% of total procedural revenue in IR practices. CPT code 37221 is similarly influential, contributing an estimated 12% to overall revenue due to its frequent application in endovascular procedures. Meanwhile, diagnostic angiography codes like 75710 and 75625 typically add around 8% each to the procedure mix’s revenue.

Utilizing these codes effectively allows IR physicians to strategically enhance their financial outcomes. By focusing on high-revenue procedures, physicians can strategically enhance their financial outcomes. Furthermore, the integration of advanced billing software tools, such as those available at GigHz Clinical Tools, supports accurate coding practices, ensuring physicians capture the maximum allowable reimbursement for services rendered.

Physicians evaluating their financial strategies should consider current market rates and procedural demand to optimize their service offerings. By staying informed of coding changes and reimbursement adjustments, IR specialists can maintain competitive net worth growth.

Last reviewed by Pouyan Golshani, MD — 2026-06-23.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — June 27, 2026